Literature DB >> 25145336

Interaction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizers.

Peng Liu1, Tapani Viitala, Alma Kartal-Hodzic, Huamin Liang, Timo Laaksonen, Jouni Hirvonen, Leena Peltonen.   

Abstract

PURPOSE: The lack of effective screening methods and systemic understanding of interaction mechanisms complicates the stabilizer selection process for nanocrystallization. This study focuses on the efficiency of stabilizers with various molecular compositions and structures to stabilize drug nanocrystals.
METHODS: Five structurally different polymers were chosen as stabilizers for indomethacin nanocrystals. The affinity of polymers onto drug surfaces was measured using surface plasmon resonance (SPR) and contact angle techniques. Nanosuspensions were prepared using the wet-ball milling technique and their physico-chemical properties were thoroughly characterized.
RESULTS: SPR and contact angle measurements correlated very well with each other and showed that the binding efficiency decreased in the order L64 > 17R4 > F68 ≈ T908 ≈ T1107, which is attributed to the reduced PPO/PEO ratio and different polymer structures. The electrostatic interactions between the protonated amine of poloxamines and ionized indomethacin enhanced neither the affinity nor the properties of nanosuspensions, such as particle size and physical stability.
CONCLUSIONS: A good stabilizer should have high binding efficiency, full coverage, and optimal hydrophobic/hydrophilic balance. A high affinity combined with short PEO chains (L64, 17R4) caused poor physical stability of nanosuspensions, whereas moderate binding efficiencies (F68, T908, T1107) with longer PEO chains produced physically stable nanosuspensions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25145336     DOI: 10.1007/s11095-014-1491-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

1.  Quantification of interactions between drug leads and serum proteins by use of "binding efficiency".

Authors:  Sofia S Gustafsson; Lotta Vrang; Ylva Terelius; U Helena Danielson
Journal:  Anal Biochem       Date:  2010-10-29       Impact factor: 3.365

2.  Development of an oral rutin nanocrystal formulation.

Authors:  Rachmat Mauludin; Rainer H Müller; Cornelia M Keck
Journal:  Int J Pharm       Date:  2008-12-07       Impact factor: 5.875

3.  Nucleation and crystal growth in supersaturated solutions of a model drug.

Authors:  Lennart Lindfors; Sara Forssén; Jan Westergren; Ulf Olsson
Journal:  J Colloid Interface Sci       Date:  2008-05-27       Impact factor: 8.128

4.  Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.

Authors:  Peng Liu; Xinyu Rong; Johanna Laru; Bert van Veen; Juha Kiesvaara; Jouni Hirvonen; Timo Laaksonen; Leena Peltonen
Journal:  Int J Pharm       Date:  2011-03-31       Impact factor: 5.875

5.  A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling.

Authors:  Ecevit Bilgili; Afolawemi Afolabi
Journal:  Int J Pharm       Date:  2012-09-24       Impact factor: 5.875

6.  Stable carbamazepine colloidal systems using the cosolvent technique.

Authors:  D Douroumis; A Fahr
Journal:  Eur J Pharm Sci       Date:  2006-12-19       Impact factor: 4.384

7.  Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice.

Authors:  Tapan K Jain; Susan P Foy; Bernadette Erokwu; Sanja Dimitrijevic; Christopher A Flask; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2009-09-17       Impact factor: 12.479

Review 8.  Drug nanocrystals in the commercial pharmaceutical development process.

Authors:  Jan P Möschwitzer
Journal:  Int J Pharm       Date:  2012-09-21       Impact factor: 5.875

9.  Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.

Authors:  Francesco Lai; Chiara Sinico; Guido Ennas; Francesca Marongiu; Giaime Marongiu; Anna Maria Fadda
Journal:  Int J Pharm       Date:  2009-02-04       Impact factor: 5.875

Review 10.  Poloxamine-based nanomaterials for drug delivery.

Authors:  Carmen Alvarez-Lorenzo; Ana Rey-Rico; Alejandro Sosnik; Pablo Taboada; Angel Concheiro
Journal:  Front Biosci (Elite Ed)       Date:  2010-01-01
View more
  11 in total

1.  In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.

Authors:  Kohei Tahara; Masahiro Nishikawa; Ko Matsui; Koji Hisazumi; Risako Onodera; Yuichi Tozuka; Hirofumi Takeuchi
Journal:  Pharm Res       Date:  2016-06-14       Impact factor: 4.200

Review 2.  Performance Parameters and Characterizations of Nanocrystals: A Brief Review.

Authors:  Manasi M Chogale; Vinod N Ghodake; Vandana B Patravale
Journal:  Pharmaceutics       Date:  2016-08-30       Impact factor: 6.321

3.  Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability.

Authors:  Hany S M Ali; Ahmed F Hanafy; Abdulmalik Alqurshi
Journal:  Int J Nanomedicine       Date:  2019-03-13

Review 4.  Advancement of nanomedicines in chronic inflammatory disorders.

Authors:  Vikas Jogpal; Mohit Sanduja; Rohit Dutt; Vandana Garg
Journal:  Inflammopharmacology       Date:  2022-02-25       Impact factor: 5.093

5.  A Systematic Approach to the Development of Cilostazol Nanosuspension by Liquid Antisolvent Precipitation (LASP) and Its Combination with Ultrasound.

Authors:  Emilia Jakubowska; Bartłomiej Milanowski; Janina Lulek
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

Review 6.  Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability.

Authors:  Annika Tuomela; Jouni Hirvonen; Leena Peltonen
Journal:  Pharmaceutics       Date:  2016-05-20       Impact factor: 6.321

Review 7.  Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques.

Authors:  Leena Peltonen
Journal:  Pharmaceutics       Date:  2018-07-25       Impact factor: 6.321

Review 8.  Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications.

Authors:  Eknath Ahire; Shreya Thakkar; Mahesh Darshanwad; Manju Misra
Journal:  Acta Pharm Sin B       Date:  2018-07-26       Impact factor: 11.413

Review 9.  Understanding Critical Quality Attributes for Nanocrystals from Preparation to Delivery.

Authors:  Leena Peltonen; Clare Strachan
Journal:  Molecules       Date:  2015-12-12       Impact factor: 4.411

10.  The Promising Role of Chitosan-Poloxamer 188 Nanocrystals in Improving Diosmin Dissolution and Therapeutic Efficacy against Ferrous Sulfate-Induced Hepatic Injury in Rats.

Authors:  Neamet S Lotfy; Thanaa M Borg; Elham A Mohamed
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.